Largest genetic study of borderline personality disorder identifies 11 risk regions and 9 genes

Jul 20, 2026

An international genome-wide association study of borderline personality disorder (BPD), analyzing data from 13,000 affected individuals and 1.1 million controls, has identified 11 risk regions and nine functional genes. Published in Nature Genetics, the study reveals that these variants account for roughly 17% of BPD's inherited risk. The findings show significant genetic overlaps with PTSD, depression, and physical conditions like COPD, opening new pathways for targeted treatments.

Borderline personality disorder GWAS findings

▪A genome-wide association study published in Nature Genetics on July 20, 2026, identified 11 genomic locations and nine functional genes associated with borderline personality disorder.
▪The genome-wide association study analyzed genetic data from approximately 13,000 individuals with borderline personality disorder and over 1.1 million control participants across 14 countries.

Polygenic risk architecture

▪A polygenic score based on the study results predicted the individual risk of developing borderline personality disorder to be 4.6% on the same scale.
▪The newly identified genetic variants account for approximately 17% to 17.3% of the inherited risk for borderline personality disorder.

Cross-disorder genetic overlaps

▪Genetic risk factors for borderline personality disorder show significant overlaps with post-traumatic stress disorder, depression, ADHD, antisocial behavior, and suicidal behavior.
▪Genetic overlaps were identified between borderline personality disorder and physical illnesses, including chronic obstructive pulmonary disease and diabetes.

Future research directions

▪Researchers emphasize the need to expand future genetic studies of borderline personality disorder to include more diverse ancestry groups beyond participants of European descent.
▪Future research aims to integrate genetic findings with clinical phenotypes and environmental exposures, such as traumatic experiences, to understand underlying biological mechanisms.

Clinical treatment implications

▪Identifying specific genes involved in borderline personality disorder could eventually help map brain circuits regulating emotions and inform the development of targeted therapeutic strategies.
▪There is currently no genetic test available for borderline personality disorder, and psychotherapy remains the primary treatment method.